BACKGROUND: Most hospitals that perform primary percutaneous coronary intervention (PCI) for ST-elevation myocardial infarction (STEMI) in the United States exceed the recommended door-to-balloon time. There is heightened interest in identifying and eliminating factors that introduce delay. METHODS: We performed a key process analysis of our primary PCI program, assessed the relative contribution of individual time intervals on total ischemic time, and identified predictors of delay. RESULTS: Median times and predictors of delay within each time interval were determined for the entire STEMI cohort ("real world") and after exclusion of patients with atypical symptoms and/or presentations of STEMI that resulted in inherent delay in diagnosis and treatment ("ideal world"). Delays in therapy were symptom onset to presentation (120 minutes [interquartile range, IQR, 60-310 minutes, ideal world] and 150 minutes [IQR 60-360 minutes, real world]; predictors of delay were peripheral vascular disease, self-transportation, daytime and weekend presentation); door-to-balloon time (118.5 minutes [IQR 96-141 minutes, ideal world] and 125 minutes [IQR 100-170 minutes, real world]; predictors of delay were female sex, previous stroke, nighttime and weekend presentation, and cardiogenic shock); and symptom onset to first balloon inflation (272 minutes [IQR 187-465 minutes, ideal world] and 297 minutes [IQR 198-560 minutes, real world]; predictors of delay were peripheral vascular disease, weekend presentation, and self-transportation). CONCLUSIONS: Key process analysis of a primary PCI program identifies treatment delays unique to the hospital and the patient population it serves.
BACKGROUND: Most hospitals that perform primary percutaneous coronary intervention (PCI) for ST-elevation myocardial infarction (STEMI) in the United States exceed the recommended door-to-balloon time. There is heightened interest in identifying and eliminating factors that introduce delay. METHODS: We performed a key process analysis of our primary PCI program, assessed the relative contribution of individual time intervals on total ischemic time, and identified predictors of delay. RESULTS: Median times and predictors of delay within each time interval were determined for the entire STEMI cohort ("real world") and after exclusion of patients with atypical symptoms and/or presentations of STEMI that resulted in inherent delay in diagnosis and treatment ("ideal world"). Delays in therapy were symptom onset to presentation (120 minutes [interquartile range, IQR, 60-310 minutes, ideal world] and 150 minutes [IQR 60-360 minutes, real world]; predictors of delay were peripheral vascular disease, self-transportation, daytime and weekend presentation); door-to-balloon time (118.5 minutes [IQR 96-141 minutes, ideal world] and 125 minutes [IQR 100-170 minutes, real world]; predictors of delay were female sex, previous stroke, nighttime and weekend presentation, and cardiogenic shock); and symptom onset to first balloon inflation (272 minutes [IQR 187-465 minutes, ideal world] and 297 minutes [IQR 198-560 minutes, real world]; predictors of delay were peripheral vascular disease, weekend presentation, and self-transportation). CONCLUSIONS: Key process analysis of a primary PCI program identifies treatment delays unique to the hospital and the patient population it serves.
Authors: Eric L Wallace; John R Kotter; Richard Charnigo; Liliana B Kuvlieva; Susan S Smyth; Khaled M Ziada; Charles L Campbell Journal: South Med J Date: 2013-07 Impact factor: 0.954
Authors: Shirley L Shih; Marisa Flavin; Richard Goldstein; Chloe Slocum; Colleen M Ryan; Aneesh Singhal; Jason Frankel; Ross Zafonte; Jeffrey C Schneider Journal: Am J Phys Med Rehabil Date: 2020-01 Impact factor: 3.412
Authors: Atsushi Sorita; Adil Ahmed; Stephanie R Starr; Kristine M Thompson; Darcy A Reed; Larry Prokop; Nilay D Shah; M Hassan Murad; Henry H Ting Journal: BMJ Date: 2014-01-21
Authors: Pria M D Nippak; Jodie Pritchard; Robin Horodyski; Candace J Ikeda-Douglas; Winston W Isaac Journal: BMC Health Serv Res Date: 2014-10-01 Impact factor: 2.655
Authors: Tomoya T Hinohara; Hussein R Al-Khalidi; Christopher B Fordyce; Xiangqiong Gu; Matthew W Sherwood; Mayme L Roettig; Claire C Corbett; Lisa Monk; Jacqueline E Tamis-Holland; Peter B Berger; J E B Burchenal; B Hadley Wilson; James G Jollis; Christopher B Granger Journal: J Am Heart Assoc Date: 2017-10-24 Impact factor: 5.501
Authors: Wen Jun Sim; An Shing Ang; Mae Chyi Tan; Wen Wei Xiang; David Foo; Kwok Kong Loh; Fahim Haider Jafary; Timothy James Watson; Paul Jau Lueng Ong; Hee Hwa Ho Journal: PLoS One Date: 2017-09-21 Impact factor: 3.240